State of Michigan Retirement System Sells 200 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

State of Michigan Retirement System trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC) by 0.6% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 35,588 shares of the company’s stock after selling 200 shares during the period. State of Michigan Retirement System’s holdings in Henry Schein were worth $2,688,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in HSIC. McGlone Suttner Wealth Management Inc. bought a new stake in Henry Schein in the 4th quarter worth about $39,000. Neo Ivy Capital Management bought a new position in shares of Henry Schein during the 3rd quarter valued at approximately $46,000. Mather Group LLC. bought a new position in shares of Henry Schein during the 1st quarter valued at approximately $97,000. Benjamin F. Edwards & Company Inc. grew its position in shares of Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock valued at $114,000 after acquiring an additional 416 shares during the period. Finally, GAMMA Investing LLC bought a new position in shares of Henry Schein during the 4th quarter valued at approximately $115,000. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Performance

NASDAQ HSIC opened at $64.79 on Thursday. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The stock has a market capitalization of $8.30 billion, a PE ratio of 21.89, a P/E/G ratio of 1.58 and a beta of 0.87. The company’s 50 day simple moving average is $69.46 and its two-hundred day simple moving average is $72.70.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same period in the prior year, the company posted $1.21 EPS. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. Analysts predict that Henry Schein, Inc. will post 5.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HSIC. UBS Group reduced their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Jefferies Financial Group increased their target price on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Barrington Research raised their price objective on shares of Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, May 8th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Henry Schein currently has a consensus rating of “Hold” and an average target price of $81.73.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.